コンテンツへスキップ
Merck
すべての画像(2)

資料

59353-U

Supelco

Discovery® C8 HPLC Column

5 μm particle size, L × I.D. 15 cm × 4.6 mm

ログイン組織・契約価格を表示する
すべての画像(2)

About This Item

UNSPSCコード:
41115700
eCl@ss:
32110501
NACRES:
SB.52

物質

stainless steel column

品質水準

100

認証

suitable for USP L7

製品種目

Discovery®

特徴

endcapped

メーカー／製品名

Discovery®

包装

1 ea of

標識化の程度

7.5% Carbon loading

パラメーター

≤70 °C temp. range
400 bar pressure (5801 psi)

テクニック

HPLC: suitable
LC/MS: suitable

L × 内径

15 cm × 4.6 mm

表面積

200 m2/g

表面被覆率

3.4 μmol/m2

不純物

<10 ppm metals

マトリックス

silica gel, high purity, spherical base material
fully porous particle

マトリックス活性基

C8 (octyl) phase

粒径

5 μm

ポアサイズ

180 Å

operating pH range

2-8

アプリケーション

food and beverages

分離法

reversed phase

類似した製品をお探しですか？ 訪問 製品比較ガイド

関連するカテゴリー

アプリケーション

Discovery® C8 HPLC column has been used in the separation of fluoroquinolone antibiotics in tablets using reversed-phase high-performance liquid chromatography (RP-HPLC).

特徴および利点

  • Excellent reproducibility
  • Faster separation of strongly hydrophobic analytes than C18 columns
  • Stable, low-bleed LC-MS separations
  • Exceptional peak shapes for basic and acidic compounds
  • Compatible with low organic/highly aqueous mobile phases

法的情報

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

Choose from one of the most recent versions:

試験成績書（COA）

Lot/Batch Number
281287-06
281287-05
281287-04
281287-03
281287-02

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Scott C Bell et al.
Pharmacology & therapeutics, 145, 19-34 (2014-06-17)
With the discovery of the CFTR gene in 1989, the search for therapies to improve the basic defects of cystic fibrosis (CF) commenced. Pharmacological manipulation provides the opportunity to enhance CF transmembrane conductance regulator (CFTR) protein synthesis and/or function. CFTR
Bo-Rui Kang et al.
Bioorganic & medicinal chemistry letters, 25(24), 5808-5812 (2015-11-08)
2-Benzylisoquinolin-1(2H)-ones has been proposed as vasodilative agents on the basis of scaffold hopping. In the present study, a series of 2-benzylisoquinolin-1(2H)-ones were synthesized. Their vasodilative effects were evaluated by wire myograph on isolated rat mesenteric arterial ring induced contraction with
Hugo M Botelho et al.
Scientific reports, 5, 9038-9038 (2015-03-13)
Plasma membrane proteins are essential molecules in the cell which mediate interactions with the exterior milieu, thus representing key drug targets for present pharma. Not surprisingly, protein traffic disorders include a large range of diseases sharing the common mechanism of
M Q Zhang et al.
Die Pharmazie, 46(10), 687-700 (1991-10-01)
The rapid growth in the quinolone research changed the whole face of the previous SAR concepts. So far structural modifications at all positions of the quinolone nucleus except the 4-oxo group have successfully lead to the discovery of potent antimicrobial
G L Bundy et al.
The Journal of biological chemistry, 261(2), 747-751 (1986-01-15)
The gorgonian coral Pseudoplexaura porosa contains a lipoxygenase capable of converting exogenous arachidonic acid into (8R)-8-hydroperoxy-5,9,11,14-eicosatetraenoic acid. The (8R)- (or 8-L-) configuration in this product, opposite to that observed in previously reported 8-lipoxygenase products, was determined unambiguously by comparison of
関連する文献をすべて表示

関連コンテンツ

Discovery C18 and C8 HPLC Columns

Discovery C18 and C8 HPLC Columns products offered

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら（テクニカルサービス）